Candida albicans (C. albicans) is a dimorphic pathogenic fungus which causes life-threatening candidemia and disseminated candidiasis [1]. Pathogenic fungi can form biofilms on medical catheters, implanted devices, heart valves, dentures and others, hereby protecting themselves with self-produced extracellular matrix and biofilm cells become resistant to antifungals [2]. C. albicans formed biofilms can develop highly resistance to a first-choice drug fluconazole, which is used to treat C. albicans infections [3]. Therefore, combined antifungal treatment is considered as a relevant tool.
Aim. To evaluate the synergistic antifungal effects of pyridinium compounds (IB-254, IB-358 and IB-385) in combination with fluconazole against C. albicans biofilms and planktonic cells.
Material and methods. The susceptibility of C. albicans standard strain ATCC® 10231TM and clinical strain 11017, isolated from patients' ascitic fluid was tested against combinations of fluconazole and pyridinium compounds. For planktonic cells studies the overnight culture was transferred to 96-well polystyrene plates with modified RPMI-1640 medium, supplemented with 2% glucose and L-glutamine, without sodium bicarbonate, and buffered with 0.165 M 4-morpholinepropanesulfonic acid (MOPS) to pH 7.0 in the presence of different concentrations of fluconazole (0.002 – 1 μg/ml) and constant concentration of pyridinium compounds (4 μg/ml of IB-254 and IB-358, 2 μg/ml of IB-385). The cells were incubated for 24 h without shaking at 37 °C. To assess the growth, ODs of planktonic yeast suspensions were measured spectrophotometrically at 612 nm using the TECAN GENios ProTM plate reader.
For better adherence biofilms of C. albicans were developed in the medium without glucose in 96-well flat bottom polystyrene plates for 90 min at 37 °C, washed twice with PBS. Biofilms were grown for 24 h in the presence of tested compounds and their combinations. Metabolic activity of biofilm cells was determined using 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay.
Results. In case of fluconazole, 1 μg/ml efficiently inhibited the growth of planktonic cells of both C. albicans strains, while biofilms were more resistant. Fluconazole at concentration of 2048 μg/ml was not able to completely inhibit biofilm formation. Pyridinium compounds, at concentrations of 4 μg/ml for IB-254 and IB-358, 2 μg/ml for IB-385, had no significant fungicidal effect on the tested C. albicans cells. Whereas, in combination with a low concentration of fluconazole (4 μg/ml) pyridinium compounds demonstrated significant synergism against C. albicans biofilms and planktonic cells of standard and clinical strains.
Conclusions. Our study demonstrated that combination of pyridinium compounds with fluconazole is effective against C. albicans. Pyridinium compounds could be promising candidates in the development of new antifungal drugs.